These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18509380)

  • 1. Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue.
    Duerner LJ; Schwantes A; Schneider IC; Cichutek K; Buchholz CJ
    Gene Ther; 2008 Nov; 15(22):1500-10. PubMed ID: 18509380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells.
    Hartl I; Schneider RM; Sun Y; Medvedovska J; Chadwick MP; Russell SJ; Cichutek K; Buchholz CJ
    Gene Ther; 2005 Jun; 12(11):918-26. PubMed ID: 15716977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases.
    Schneider RM; Medvedovska Y; Hartl I; Voelker B; Chadwick MP; Russell SJ; Cichutek K; Buchholz CJ
    Gene Ther; 2003 Aug; 10(16):1370-80. PubMed ID: 12883534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
    Engelstädter M; Buchholz CJ; Bobkova M; Steidl S; Merget-Millitzer H; Willemsen RA; Stitz J; Cichutek K
    Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
    Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A
    Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases.
    Springfeld C; von Messling V; Frenzke M; Ungerechts G; Buchholz CJ; Cattaneo R
    Cancer Res; 2006 Aug; 66(15):7694-700. PubMed ID: 16885371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
    Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
    Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.
    Wei J; Wahl J; Nakamura T; Stiller D; Mertens T; Debatin KM; Beltinger C
    Gene Ther; 2007 Nov; 14(22):1573-86. PubMed ID: 17898797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
    Thorne SH; Hermiston T; Kirn D
    Semin Oncol; 2005 Dec; 32(6):537-48. PubMed ID: 16338419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
    Kohno SI; Luo C; Nawa A; Fujimoto Y; Watanabe D; Goshima F; Tsurumi T; Nishiyama Y
    Cancer Gene Ther; 2007 Nov; 14(11):918-26. PubMed ID: 17693992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended release of adenovirus from silica implants in vitro and in vivo.
    Kangasniemi L; Koskinen M; Jokinen M; Toriseva M; Ala-Aho R; Kähäri VM; Jalonen H; Ylä-Herttuala S; Moilanen H; Stenman UH; Diaconu I; Kanerva A; Pesonen S; Hakkarainen T; Hemminki A
    Gene Ther; 2009 Jan; 16(1):103-10. PubMed ID: 18754041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice.
    Hung CF; Tsai YC; He L; Coukos G; Fodor I; Qin L; Levitsky H; Wu TC
    Gene Ther; 2007 Jan; 14(1):20-9. PubMed ID: 16915291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases.
    Kinoh H; Inoue M; Washizawa K; Yamamoto T; Fujikawa S; Tokusumi Y; Iida A; Nagai Y; Hasegawa M
    Gene Ther; 2004 Jul; 11(14):1137-45. PubMed ID: 15085175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors.
    Schaser T; Wrede C; Duerner L; Sliva K; Cichutek K; Schnierle B; Buchholz CJ
    Gene Ther; 2011 Oct; 18(10):953-60. PubMed ID: 21472010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
    Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
    Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of tumour cells for delivering oncolytic viruses.
    Raykov Z; Rommelaere J
    Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
    Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
    Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.